Sepsis, Septic Shock, and Differences in Cardiovascular Event Occurrence

被引:7
作者
Falk, Grace E. [1 ]
Rogers, Jerad [1 ]
Lu, Liuqiang [2 ]
Ablah, Elizabeth [2 ]
Okut, Hayrettin [2 ]
Vindhyal, Mohinder R. [3 ]
机构
[1] Univ Kansas, Sch Med, Wichita, KS 67214 USA
[2] Univ Kansas, Sch Med, Dept Populat Hlth, Wichita, KS 67214 USA
[3] Kansas Univ, Dept Cardiovasc Dis, Med Ctr, 3901 Rainbow Blvd,Mailstop 4023, Kansas City, KS 66160 USA
关键词
sepsis; septic shock; acute kidney injury; myocardial infarction; heart failure; CARDIOGENIC-SHOCK; HEART-FAILURE; MORTALITY; PATHOPHYSIOLOGY; MANAGEMENT; TRENDS;
D O I
10.1177/08850666221083644
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Mortality estimates from sepsis and septic shock ranged from 18% to 35% and 40% to 60%, respectively, prior to 2014. Sepsis patients who experience subsequent cardiovascular events have increased mortality; however, data are limited among septic shock patients. This study reports in-hospital mortality, incident cardiovascular events, and cardiovascular procedures among sepsis patients with and without subsequent septic shock. Methods: Patients with a primary diagnosis of sepsis with and without a secondary diagnosis of septic shock were identified from the 2016 and 2017 National Readmissions Database. These patients were then evaluated for the occurrence of cardiovascular events and procedures. Results: A total of 2,127,137 patients were included in the study, with a mean age of 66 years. Twenty percent of patients (n = 420,135) developed subsequent septic shock. In-hospital mortality among patients with a primary diagnosis of sepsis was 5.3%, and it was 31.2% for those with subsequent septic shock. Notable cardiovascular events occurring among sepsis patients with and without subsequent septic shock, respectively, included: acute kidney injury (65.1% vs. 32.8%, P < .0001), acute systolic heart failure (9.8% vs. 5.1%, P < .0001), NSTEMI (8.8% vs. 3.2%, P < .0001), and ischemic stroke (2.3% vs. 0.9%, P < .0001). Similarly, the most common cardiovascular procedures between the two groups were: percutaneous coronary intervention (0.37% vs. 0.20%, P < .0001), intra-aortic balloon pump (0.19% vs. 0.02%, P < .0001), and extracorporeal membrane oxygenation (0.18% vs. 0.01%, P < .0001). Conclusions: Sepsis with subsequent septic shock is associated with an increased frequency of in-hospital cardiovascular events and procedures.
引用
收藏
页码:1528 / 1534
页数:7
相关论文
共 54 条
  • [11] CDC, 2020, SEPS DAT REP
  • [12] CDC, 2020, STROKE
  • [13] Sepsis and septic shock
    Cecconi, Maurizio
    Evans, Laura
    Levy, Mitchell
    Rhodes, Andrew
    [J]. LANCET, 2018, 392 (10141) : 75 - 87
  • [14] Effect of Performance Improvement Programs on Compliance with Sepsis Bundles and Mortality: A Systematic Review and Meta-Analysis of Observational Studies
    Damiani, Elisa
    Donati, Abele
    Serafini, Giulia
    Rinaldi, Laura
    Adrario, Erica
    Pelaia, Paolo
    Busani, Stefano
    Girardis, Massimo
    [J]. PLOS ONE, 2015, 10 (05):
  • [15] Diabetes prevalence and diagnosis in US states: Analysis of health surveys
    Danaei G.
    Friedman A.B.
    Oza S.
    Murray C.J.L.
    Ezzati M.
    [J]. Population Health Metrics, 7 (1) : 16
  • [16] Diagnostic Accuracy of the Explicit Diagnostic Criteria for Transient Ischemic Attack: A Validation Study
    Dolmans, L. Servaas
    Lebedeva, Elena R.
    Veluponnar, Dinusha
    van Dijk, Ewoud J.
    Nederkoorn, Paul J.
    Hoes, Arno W.
    Rutten, Frans H.
    Olesen, Jes
    Kappelle, L. Jaap
    Badelink, M. E. L.
    Rutten, F. H.
    Hoes, A. W.
    Kappelle, L. J.
    van Dijk, E. J.
    Nederkoorn, P. J.
    van Delft, S.
    Seppenwoolde, G. J.
    [J]. STROKE, 2019, 50 (08) : 2080 - 2085
  • [17] Comorbidity measures for use with administrative data
    Elixhauser, A
    Steiner, C
    Harris, DR
    Coffey, RN
    [J]. MEDICAL CARE, 1998, 36 (01) : 8 - 27
  • [18] Extracorporeal Membrane Oxygenation for Septic Shock
    Falk, Lars
    Hultman, Jan
    Broman, Lars Mikael
    [J]. CRITICAL CARE MEDICINE, 2019, 47 (08) : 1097 - 1105
  • [19] Farmakis D, 2015, REV ESP CARDIOL, V68, P245, DOI [10.1016/j.rec.2014.11.004, 10.1016/j.recesp.2014.11.009]
  • [20] Frangogiannis NG, 2015, COMPR PHYSIOL, V5, P1841, DOI 10.1002/cphy.c150006